What is the recommended intrapartum fetal surveillance for a multi-gravida (woman who has been pregnant more than once) at 38 weeks with induction of labor due to intrauterine growth restriction (IUGR) and who is medically free?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intrapartum Fetal Surveillance for IUGR at 38 Weeks

Continuous fetal monitoring (Option D) is the recommended intrapartum surveillance method for this patient undergoing induction of labor for IUGR at 38 weeks.

Rationale for Continuous Electronic Fetal Monitoring

Multiple international guidelines consistently recommend continuous cardiotocography (CTG) during labor for pregnancies complicated by fetal growth restriction:

  • The UK, New Zealand, and French guidelines explicitly state that induction of labor with continuous CTG is recommended when umbilical artery end-diastolic flow is present in IUGR cases 1

  • The Society for Maternal-Fetal Medicine emphasizes that routine cesarean delivery for FGR is not recommended, but continuous fetal monitoring in labor is essential 1

  • Labor represents a particularly high-risk period for IUGR fetuses, as uterine contractions reduce uteroplacental perfusion by up to 60%, and these compromised fetuses can quickly decompensate once contractions begin 2, 3

Why Not Intermittent Auscultation?

While intermittent auscultation is appropriate for low-risk pregnancies 4, IUGR specifically qualifies as a high-risk condition requiring continuous electronic fetal monitoring 4. The Canadian guidelines state that continuous intrapartum electronic fetal monitoring is recommended "for pregnancies where there is an increased risk of perinatal death, cerebral palsy, or neonatal encephalopathy" - all of which apply to IUGR 4.

Clinical Context at 38 Weeks

At 38 weeks with IUGR and normal Doppler studies (implied by proceeding with induction rather than earlier delivery):

  • Delivery timing aligns with guideline recommendations of 37-39 weeks for IUGR with normal umbilical artery Doppler 1

  • The fetus remains at increased risk during labor despite reaching term gestation, necessitating heightened surveillance 2, 3

Important Caveats

  • Continuous monitoring should be paired with appropriate interpretation and response protocols, as electronic fetal monitoring requires proper training and understanding of fetal physiology at different gestational ages 5

  • If non-reassuring patterns develop during continuous monitoring, escalation to fetal scalp blood sampling or expedited delivery should be considered 4

  • While maternal vital signs monitoring (Option C) is standard obstetric care, it does not constitute adequate fetal surveillance for this high-risk scenario 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intrauterine restriction (IUGR).

Journal of perinatal medicine, 2008

Research

Fetal health surveillance in labour.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2002

Research

On intrapartum fetal monitoring.

American journal of obstetrics and gynecology, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.